Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride

AAPS PharmSciTech

Volumn 8, Issue 1, 2007, Pages

  Patel, Vishnu M ^a   Prajapati, Bhupendra G ^a   Patel, Madhabhai M ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

Bilayered buccal tablet; Buccal delivery; Mucoadhesion; Multilayered buccal tablet; Propanolo hydrocholoride

Indexed keywords

CARBOPOL 934; CARBOXYMETHYLCELLULOSE; ETHYL CELLULOSE; MANNITOL; POVIDONE; PROPRANOLOL; BIOMATERIAL; DRUG;

ANIMAL TISSUE; ARTICLE; BUCCAL DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; EX VIVO STUDY; FIRST PASS EFFECT; HUMAN; IN VITRO STUDY; NONHUMAN; PH; SALIVA; TABLET COMPRESSION; TABLET FORMULATION; TABLET HARDNESS; TABLET PROPERTY; TABLET THICKNESS; ADHESION; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; MOUTH MUCOSA; SHEEP; SURFACE PROPERTY; TABLET;

ADHESIVENESS; ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DIFFUSION; HUMANS; MOUTH MUCOSA; PHARMACEUTICAL PREPARATIONS; PROPRANOLOL; SALIVA; SHEEP; SURFACE PROPERTIES; TABLETS;

EID: 33947681178     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0801022     Document Type: Article

References (29)

1. Anders R, Merkle HP. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int J Pharm. 1989;49:231-240.
2. Chen WG, Hwang G. Adhesive and in vitro release characteristics of propranolol bioadhesive disc system. Int J Pharm. 1992;82:61-66.
3. Alur HH, Pather SI, Mitra AK. Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel natural mucoadhesive gum as an excipient in buccal tablets. Int J Pharm. 1999;188:1-10.
4. Guo JH. Bioadhesive polymer buccal patches for buprenorphine-controlled delivery: formulation in vitro adhesion and release properties. Drug Dev Ind Pharm. 1994;20:2809-2821.
5. Ahuja A, Dorga M, Agarwal SP. Development of buccal tablets of diltiazem hydrochloride. Indian J Pharm Sci. 1995;57:26-30.
6. Nagai T, Konishi R. Buccal/gingival drug delivery systems. J Control Release. 1987;6:353-360.
7. Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci. 1992;81:1-10.
8. Dortunc B, Ozer L, Uyanik N. Development and in vitro evaluation of a buccoadhesive pindolol tablet formulation. Drug Dev Ind Pharm. 1998;24:281-288.
9. Schor JM, Davis SS, Nigalaye A, Bolton S. Susadrin transmucosal tablets (nitroglycerin in synchron-controlled release base). Drug Dev Ind Pharm. 1983;9:1359-1377.
10. Ishida M, Nambu N, Nagai T. Highly viscous gel ointment containing Carbopol for application to the oral mucosa. Chem Pharm Bull (Tokyo). 1983;31:4561-4564.
11. Bremecker KD, Strempel H, Klein G. Novel concept for a mucosal adhesive ointment. J Pharm Sci. 1984;73:548-552.
12. Gu JM, Robinson JR, Leung SHS. Binding of acrylic polymers to mucin/ epithelial surfaces: structure-property relationships. Crit Rev Ther Drug Carrier Syst. 1988;5:21-67.
13. Duchene DE, Touchard F, Pappas NA. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm. 1988;14:283-318.
14. Desai KGH, Kumar TMP. Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech. 2004;5:article 35.
15. Remunan-Lopez C, Portero A, Vila-Jato JL, Alonso MJ. Design and evaluation of chitosan/ ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release. 1998;55:143-152.
16. Cid E, Mella F, Lucchini L, Carcamo M, Monasterio J. Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man. Biopharm Drug Dispos. 1986;7:559-566.
17. Walle T, Conradi EC, Walle UK, Fagan TC, Gaffney TE. The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin Pharmacol Ther. 1978;24:668-677.
18. Gupta A, Garg S, Khar RK. Measurement of bioadhesive strength of muco-adhesive buccal tablets: design of an in-vitro assembly. Indian Drugs. 1992;30:152-155.
19. Parodi B, Russo E, Caviglioli G, Cafaggi S, Bignardi G. Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev Ind Pharm. 1996;22:445-450.
20. Bottenberg P, Cleymaet R, Muynek CD, Remon JP, Coomans D, Slop D. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol. 1991;43: 457-464.
21. Han RY, Fang JY, Sung KC, Hu OYP. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm. 1999;177:201-209.
22. Pharmacopoeia of India. New Delhi, India: Controller of Publications Ministry of Health and Welfare, Government of India; 1996:634.
23. Guo JH, Cooklock M. The effect of backing materials and multilayered systems on the characteristics of bioadhesive buccal patches. J Pharm Pharmacol. 1996;48:255-257.
24. Peppas NA, Bury PA. Surface interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release. 1985;2:257-275.
25. Park H, Robinson JR. Mechanisms of bioadhesion of poly (acrylic acid) hydrogels. Pharm Res. 1987;4:457-464.
26. Ilango R, Kavimani S, Mullaicharam AR, Jayakar B. In vitro studies on buccal strips of glibenclamide using chitosan. Indian J Pharm Sci. 1997;59:232-235.
27. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110-111.
28. Choi HG, Kim CK. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release. 2000;68:397-404.
29. Anlar S, Capan Y, Hincal A. Physico-chemical and bioadhesive properties of polyacrylic acid polymers. Pharmazie. 1993;48:285-287.